By Brazil Stock Guide – Oncoclínicas do Brasil Serviços Médicos S.A. (B3: ONCO3) has sold all debentures it held in treasury — 55,200 from its 9th issuance and 135,500 from its 11th — in a transaction that brought in a total of R$111.2 million ($19.3 million). The operation, approved by the board on October 24 and completed on Monday (27), aims to strengthen the company’s cash position amid tighter financing conditions in Brazil’s healthcare sector.
The company, which runs one of the largest private cancer-treatment networks in Latin America, has been under growing scrutiny from investors after a series of market operations and governance debates involving minority shareholders. The sale provides a liquidity boost that comes at a time when several issuers in the segment — from diagnostics groups to hospital chains — are seeking ways to reduce leverage without tapping volatile bond markets.
Chief Financial and Investor Relations Officer Cristiano Affonso Ferreira de Camargo said the operation’s goal was simply to reinforce Oncoclínicas’ financial position. The transaction, he noted, allows the company to maintain operational flexibility and prepare for upcoming maturities without relying on new debt issuance.
Last week, Oncoclínicas reached an agreement with Banco Master de Investimento S.A. to restructure the redemption schedule of R$478.2 million in bank deposit certificates (CDBs). The repayment will be made in 20 installments between October 2025 and May 2027, maintaining the original interest rate.
Leave a Reply